课题基金 / 基金详情

Development of novel systems for evaluation and prediction of drug inteactions based on the reconstruction of drug excretion systems in vitro.

Development of novel systems for evaluation and prediction of drug inteactions based on the reconstruction of drug excretion systems in vitro.
基于体外药物排泄系统重建的药物相互作用评估和预测的新系统的开发。
批准号:
09557211
负责人:
INUI Ken-ichi
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

INUI Ken-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have studied the development of novel systems for evaluation and prediction of drug interactions based on the reconstruction of drug excretion systems in vitro.First, we cloned and characterized two renal organic anion transporters, OAT1 and OAT-K2. Using X enopus oocyte expression system, OAT1 mediated various organic anion uptake, and the OAT1-mediated p-aminohippuric acid uptake was markedly inhibited in the presence of various anionic diuretics. In addition, OAT-K2 mediated transport of hydrophobic organic anions (Masuda et al., Mol. Pharmacol., 55,743-752,1999).Second, We have constructed the various transfectants, stably expressing OAT-K1, OAT-K2, renal organic cation transporter OCT1 and OCT2, respectively. The OAT-K1-mediated methotrexate transport was competitively inhibited by nonsteroidal antiinflammatory drugs such as indomethacin and ketoprofen (Masuda et al., J. Pharmacol. Exp. Ther., 283, 1039-1043, 1997), The OCT1-and OCT2-mediated tetraethylammonium uptake was markedly inhibited by various cationic drugs, such as tetraalkylammoniums, antiarrthythmis, endogenous metabolite NィイD11ィエD1-methylnicotinamide and guanidine (Urakami et al., J. Pharmacol. Exp. Ther., 287, 800-805, 1998). In addition, we demonstrated the inhibitory effect of clarithromycin on renal excretion of digoxin via P-glycoprotein (Wakasugi et al., Clin. Ther., 64, 123-128,1998).These results suggest that the drug transporter expressing systems appeared to be useful for evaluating and predicting the transporter-mediated drug interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
K.Inui: "Cellular and molecular mechanisms of renal tubular secretion of organic anions and cations." Clin.Exp.Nephrol.2・2. 100-108 (1998)
K.Inui:“肾小管分泌有机阴离子和阳离子的细胞和分子机制。”Clin.Exp.Nephrol.2·2(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Masuda: "Functional analysis of rat renal organic anion transporter OAT-K1: bidirectional methotrexate transport in apical membrane"FEBS Lett.. 459・1. 128-132 (1999)
S.Masuda:“大鼠有机阴离子转运蛋白 OAT-K1 的功能分析:顶膜中的双向甲氨蝶呤转运”FEBS Lett.. 459・1(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masuda,S.: "Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney"Mol. Pharmacol.. 55. 743-752 (1999)
Masuda,S.:“大鼠肾脏中新型多特异性有机阴离子转运蛋白 OAT-K2 的克隆和功能表征”Mol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroko Wakasugi et al.: "Effect of clarithromycin on renal excretion of digoxin : interaction with P-glycoprotein."Clin. Pharmacol. Ther.. 64. 123-128 (1998)
Hiroko Wakasugi 等人:“克拉霉素对地高辛肾排泄的影响:与 P-糖蛋白的相互作用”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    PHARMACOKINETICS IN THE PATIENTS WITH METABOLIC SYNDROME AND APPLICATION FOR PHARMACOTHERAPY
    • 批准号:
      20249036
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.03万
    • 财政年份:
      2008
    • 负责人:
      INUI Ken-ichi
    • 依托单位:
    Establishment of personalized immunosuppressive therapy based on molecular mechanisms of transplant immunological network
    • 批准号:
      16209005
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.53万
    • 财政年份:
      2004
    • 负责人:
      INUI Ken-ichi
    • 依托单位:
    Evaluation of drug interaction and interindividual differences of renal drug excretion based on the genetic polymorphism analysis
    • 批准号:
      13307068
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.95万
    • 财政年份:
      2001
    • 负责人:
      INUI Ken-ichi
    • 依托单位:
    Molecular diversity of organic ion transporters and their roles in the renal drug excretion
    • 批准号:
      11470495
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.41万
    • 财政年份:
      1999
    • 负责人:
      INUI Ken-ichi
    • 依托单位:
    海外基金